Related Experiment Video
Updated: Mar 16, 2026

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks
Published on: December 2, 2022
Advances in fucoidan extraction and structure-bioactivity relationships
Emmanuel Ofosu Mensah1, Jens Sommer-Knudsen2, Morten Thaysen-Andersen3
1School of Natural Sciences, Macquarie University, Sydney, NSW, 2109, Australia; Australian Research Council Industrial Transformation Training Centre for Facilitated Advancement of Australia's Bioactives (FAAB), Sydney, NSW, 2109, Australia.
Abstract:
Fucoidan is a sulfated polysaccharide from brown seaweeds whose heterogeneous structure and broad bioactivities have stimulated extensive investigation. While primarily composed of fucose, its composition varies in monosaccharide content (e.g. galactose, xylose, mannose, glucuronic acid), backbone architecture, branching, and sulfation patterns, with these features influenced by species, environmental factors, and extraction conditions. Because extraction methods can preserve or degrade structural motifs essential to bioactivity, methodological variation has contributed to longstanding inconsistencies in reported structure-bioactivity relationships. This review critically explores advances in fucoidan extraction, including emerging optimization strategies and sequential extraction approaches, and evaluates their effects on yield, purity, and structural integrity. We further examine recent developments in understanding structure-bioactivity relationships, highlighting insights derived from molecular docking, multi-omics platforms, and integrative systems-level analyses. Together, these perspectives provide a consolidated framework for relating extraction conditions, structural characteristics, and biological function in fucoidan research.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

